4//SEC Filing
North Annette 4
Accession 0001209191-22-008981
CIK 0001595893other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 6:09 PM ET
Size
12.1 KB
Accession
0001209191-22-008981
Insider Transaction Report
Form 4
North Annette
EVP, General Counsel & Secty.
Transactions
- Award
Common Stock
2022-02-09+16,283→ 27,979 total - Award
Stock Option (right to buy)
2022-02-09+58,600→ 58,600 totalExercise: $37.68Exp: 2032-02-08→ Common Stock (58,600 underlying) - Sale
Common Stock
2022-02-09$36.30/sh−669$24,285→ 11,696 total
Footnotes (3)
- [F1]Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on February 8, 2021.
- [F2]Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan.
- [F3]1/48th of the shares vest monthly following February 9, 2022.
Issuer
Turning Point Therapeutics, Inc.
CIK 0001595893
Entity typeother
Related Parties
1- filerCIK 0001341011
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 6:09 PM ET
- Size
- 12.1 KB